0 Items
+1.855.816.PALS (7257) [email protected]

CPG Sec.160.200 FDA Use of Income Tax Information from IRS

by | Oct 26, 2024 | News

Issued by: Guidance Issuing Office Office of Regulatory Affairs BACKGROUND: The Food and Drug Administration has used income tax information from the Internal Revenue Service in the past to aid the agency’s investigative efforts. POLICY: The policy of the agency...

CPG Sec. 110.500 Food and Drug Guaranty

by | Oct 26, 2024 | News

Issued by: Guidance Issuing Office Office of Regulatory Affairs BACKGROUND: A district compliance officer has inquired if a domestic distributor can take advantage of the immunity offered by 21 USC 333(c)(2) by obtaining from a foreign manufacturer, or his resident...

CPG Sec. 270.100 Final Container Labels

by | Oct 26, 2024 | News

Issued by: Guidance Issuing Office Office of Regulatory Affairs Compliance Policy Guide 270.100 Final Container Labels – Allergenic Extracts Containing Glycerin; Reporting Changes is obsolete and was withdrawn on 1/30/2020. Issued: 7/19/76Revised: 10/1/80,...

CPG 230.120- Human Blood and Blood Products as Drugs

by | Oct 26, 2024 | News

Issued by: Guidance Issuing Office Office of Regulatory Affairs Compliance Policy Guide Sec. 230.120- Human Blood and Blood Products As Drugs is obsolete and was withdrawn on 1/30/2020. Issued 6/17/74Revised 10/1/80Withdrawn: 1/30/2020   Submit Comments Submit...